Rapid reduction of central line infections in hospitalized pediatric oncology patients through simple quality improvement methods
dc.contributor.author | Choi, Sung W. | en_US |
dc.contributor.author | Chang, Lawrence | en_US |
dc.contributor.author | Hanauer, David A. | en_US |
dc.contributor.author | Shaffer‐hartman, Jacqueline | en_US |
dc.contributor.author | Teitelbaum, Daniel | en_US |
dc.contributor.author | Lewis, Ian | en_US |
dc.contributor.author | Blackwood, Alex | en_US |
dc.contributor.author | Akcasu, Nur | en_US |
dc.contributor.author | Steel, Janell | en_US |
dc.contributor.author | Christensen, Joy | en_US |
dc.contributor.author | Niedner, Matthew F. | en_US |
dc.date.accessioned | 2013-01-03T19:41:13Z | |
dc.date.available | 2014-04-02T15:08:07Z | en_US |
dc.date.issued | 2013-02 | en_US |
dc.identifier.citation | Choi, Sung W.; Chang, Lawrence; Hanauer, David A.; Shaffer‐hartman, Jacqueline ; Teitelbaum, Daniel; Lewis, Ian; Blackwood, Alex; Akcasu, Nur; Steel, Janell; Christensen, Joy; Niedner, Matthew F. (2013). "Rapid reduction of central line infections in hospitalized pediatric oncology patients through simple quality improvement methods ." Pediatric Blood & Cancer 60(2): 262-269. <http://hdl.handle.net/2027.42/95163> | en_US |
dc.identifier.issn | 1545-5009 | en_US |
dc.identifier.issn | 1545-5017 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/95163 | |
dc.description.abstract | Background Pediatric hematology–oncology (PHO) patients are at significant risk for developing central line‐associated bloodstream infections (CLA‐BSIs) due to their prolonged dependence on such catheters. Effective strategies to eliminate these preventable infections are urgently needed. In this study, we investigated the implementation of bundled central line maintenance practices and their effect on hospital‐acquired CLA‐BSIs. Materials and Methods CLA‐BSI rates were analyzed within a single‐institution's PHO unit between January 2005 and June 2011. In May 2008, a multidisciplinary quality improvement team developed techniques to improve the PHO unit's safety culture and implemented the use of catheter maintenance practices tailored to PHO patients. Data analysis was performed using time‐series methods to evaluate the pre‐ and post‐intervention effect of the practice changes. Results The pre‐intervention CLA‐BSI incidence was 2.92 per 1,000‐patient days (PD) and coagulase‐negative Staphylococcus was the most prevalent pathogen (29%). In the post‐intervention period, the CLA‐BSI rate decreased substantially (45%) to 1.61 per 1,000‐PD ( P < 0.004). Early on, blood and marrow transplant (BMT) patients had a threefold higher CLA‐BSI rate compared to non‐BMT patients ( P < 0.033). With additional infection control countermeasures added to the bundled practices, BMT patients experienced a larger CLA‐BSI rate reduction such that BMT and non‐BMT CLA‐BSI rates were not significantly different post‐intervention. Conclusions By adopting and effectively implementing uniform maintenance catheter care practices, learning multidisciplinary teamwork, and promoting a culture of patient safety, the CLA‐BSI incidence in our study population was significantly reduced and maintained. Pediatr Blood Cancer 2013;60:262–269. © 2012 Wiley Periodicals, Inc. | en_US |
dc.publisher | Wiley Subscription Services, Inc., A Wiley Company | en_US |
dc.subject.other | Pediatric Hematology Oncology | en_US |
dc.subject.other | Blood and Marrow Transplant | en_US |
dc.subject.other | Blood Stream Infections | en_US |
dc.subject.other | Central Line‐Associated Bloodstream Infection | en_US |
dc.subject.other | Children | en_US |
dc.subject.other | Hospital Acquired Infections | en_US |
dc.subject.other | Infection Control | en_US |
dc.subject.other | Quality Improvement | en_US |
dc.subject.other | CLA‐BSI | en_US |
dc.title | Rapid reduction of central line infections in hospitalized pediatric oncology patients through simple quality improvement methods | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Pediatrics | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Blood and Marrow Transplant Program, University of Michigan, 1500 E. Medical Center Drive, 5303 Cancer Center, Ann Arbor, MI 48109‐5942. | en_US |
dc.contributor.affiliationum | Division of Pediatric Critical Care, Department of Pediatrics, University of Michigan, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Michigan, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Division of Pediatric Anesthesiology, Department of Anesthesiology, University of Michigan, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Division of Pediatric Surgery, Department of Surgery, University of Michigan, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Department of Infection Control, University of Michigan, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | General Pediatrics and Informatics Core of the Comprehensive Cancer Center, Department of Pediatrics, University of Michigan, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Pediatric Hematology–Oncology, Department of Pediatrics, University of Michigan, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Department of Nursing, University of Michigan, Ann Arbor, Michigan | en_US |
dc.identifier.pmid | 22522576 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/95163/1/24187_ftp.pdf | |
dc.identifier.doi | 10.1002/pbc.24187 | en_US |
dc.identifier.source | Pediatric Blood & Cancer | en_US |
dc.identifier.citedreference | McLean TW, Fisher CJ, Snively BM, et al. Central venous lines in children with lesser risk acute lymphoblastic leukemia: Optimal type and timing of placement. J Clin Oncol 2005; 23: 3024 – 3029. | en_US |
dc.identifier.citedreference | Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter‐related bloodstream infections in the ICU. N Engl J Med 2006; 355: 2725 – 2732. | en_US |
dc.identifier.citedreference | Pronovost PJ, Goeschel CA, Colantuoni E, et al. Sustaining reductions in catheter related bloodstream infections in Michigan intensive care units: Observational study. BMJ 2010; 340: c309. | en_US |
dc.identifier.citedreference | Pronovost PJ, Berenholtz SM, Goeschel CA, et al. Creating high reliability in health care organizations. Health Serv Res 2006; 41: 1599 – 1617. | en_US |
dc.identifier.citedreference | Institute of Medicine. To Err is Human: Building a Safer Health System. 1999. http://www.iom.edu/Reports/1999/To‐Err‐is‐Human‐Building‐A‐Safer‐Health‐System.aspx. Accessed on February 28, 2012. | en_US |
dc.identifier.citedreference | Institute of Medicine. Rewarding Provider Performance: Aligning Incentives in Medicare. 2006. http://iom.edu/Reports/2006/Rewarding‐Provider‐Performance‐Aligning‐Incentives‐in‐Medicare.aspx. Accessed on February 28, 2012. | en_US |
dc.identifier.citedreference | Lindenauer PK, Remus D, Roman S, et al. Public reporting and pay for performance in hospital quality improvement. N Engl J Med 2007; 356: 486 – 496. | en_US |
dc.identifier.citedreference | Murray LJ, Lee R, Martens C. In vivo cytokine gene expression in T cell subsets of the autoimmune MRL/Mp‐Ipr/Ipr mouse. Eur J Immunol 1990; 20: 163 – 170. | en_US |
dc.identifier.citedreference | Iscove NN, Sieber F. Erythroid progenitors in mouse bone marrow detected by macroscopic colony formation in culture. Exp Haematol 1975; 3: 32 – 43. | en_US |
dc.identifier.citedreference | Costello JM, Morrow DF, Graham DA, et al. Systematic intervention to reduce central line‐associated bloodstream infection rates in a pediatric cardiac intensive care unit. Pediatrics 2008; 121: 915 – 923. | en_US |
dc.identifier.citedreference | Miller MR, Griswold M, Harris JM II, et al. Decreasing PICU catheter‐associated bloodstream infections: NACHRI's quality transformation efforts. Pediatrics 2010; 125: 206 – 213. | en_US |
dc.identifier.citedreference | Chuengchitraks S, Sirithangkul S, Staworn D, et al. Impact of new practice guideline to prevent catheter‐related blood stream infection (CRBSI): Experience at the Pediatric Intensive Care Unit of Phramongkutklao Hospital. J Med Assoc Thai 2010; 93: S79 – S83. | en_US |
dc.identifier.citedreference | Wheeler DS, Giaccone MJ, Hutchinson N, et al. A hospital‐wide quality‐improvement collaborative to reduce catheter‐associated bloodstream infections. Pediatrics 2011; 128: e995 – e1004, quiz e1004‐1007. | en_US |
dc.identifier.citedreference | Kallen AJ, Patel PR, O'Grady NP. Preventing catheter‐related bloodstream infections outside the intensive care unit: Expanding prevention to new settings. Clin Infect Dis 2010; 51: 335 – 341. | en_US |
dc.identifier.citedreference | Marra AR, Cal RG, Durao MS, et al. Impact of a program to prevent central line‐associated bloodstream infection in the zero tolerance era. Am J Infect Control 2010; 38: 434 – 439. | en_US |
dc.identifier.citedreference | Advani S, Reich NG, Sengupta A, et al. Central line‐associated bloodstream infection in hospitalized children with peripherally inserted central venous catheters: Extending risk analyses outside the intensive care unit. Clin Infect Dis 2011; 52: 1108 – 1115. | en_US |
dc.identifier.citedreference | Niedner MF, Huskins WC, Colantuoni E, et al. Epidemiology of central line‐associated bloodstream infections in the pediatric intensive care unit. Infect Control Hosp Epidemiol 2011; 32: 1200 – 1208. | en_US |
dc.identifier.citedreference | Edwards JR, Peterson KD, Mu Y, et al. National Healthcare Safety Network (NHSN) report: Data summary for 2006 through 2008, issued December 2009. Am J Infect Control 2009; 37: 783 – 805. | en_US |
dc.identifier.citedreference | Simon A, Fleischhack G, Hasan C, et al. Surveillance for nosocomial and central line‐related infections among pediatric hematology–oncology patients. Infect Control Hosp Epidemiol 2000; 21: 592 – 596. | en_US |
dc.identifier.citedreference | Wurzel CL, Halom K, Feldman JG, et al. Infection rates of Broviac–Hickman catheters and implantable venous devices. Am J Dis Child 1988; 142: 536 – 540. | en_US |
dc.identifier.citedreference | Farr BM. Vascular catheter related infections in cancer patients. Surg Oncol Clin N Am 1995; 4: 493 – 503. | en_US |
dc.identifier.citedreference | Link H, Bohme A, Cornely OA, et al. Antimicrobial therapy of unexplained fever in neutropenic patients–guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG‐German Cancer Society). Ann Hematol 2003; 82: S105 – S117. | en_US |
dc.identifier.citedreference | Abbas AA, Fryer CJ, Paltiel C, et al. Factors influencing central line infections in children with acute lymphoblastic leukemia: Results of a single institutional study. Pediatr Blood Cancer 2004; 42: 325 – 331. | en_US |
dc.identifier.citedreference | Wylie MC, Graham DA, Potter‐Bynoe G, et al. Risk factors for central line‐associated bloodstream infection in pediatric intensive care units. Infect Control Hosp Epidemiol 2010; 31: 1049 – 1056. | en_US |
dc.identifier.citedreference | Ingram J, Weitzman S, Greenberg ML, et al. Complications of indwelling venous access lines in the pediatric hematology patient: A prospective comparison of external venous catheters and subcutaneous ports. Am J Pediatr Hematol Oncol 1991; 13: 130 – 136. | en_US |
dc.identifier.citedreference | Adler A, Yaniv I, Solter E, et al. Catheter‐associated bloodstream infections in pediatric hematology–oncology patients: Factors associated with catheter removal and recurrence. J Pediatr Hematol Oncol 2006; 28: 23 – 28. | en_US |
dc.identifier.citedreference | Adler A, Yaniv I, Steinberg R, et al. Infectious complications of implantable ports and Hickman catheters in paediatric haematology–oncology patients. J Hosp Infect 2006; 62: 358 – 365. | en_US |
dc.identifier.citedreference | CDC. National Vital Statistics; 2009. http://www.cdc.gov/HAI/bsi/bsi.html. Accessed on February 28, 2012. | en_US |
dc.identifier.citedreference | Scott RD., The Direct Medical Costs of Healthcare‐Associated Infections in U.S. Hospitals and the Benefits of Prevention: CDC. http://www.cdc.gov/ncidod/dhqp/pdf/Scott_CostPaper.pdf; 2009. Accessed on February 28, 2012. | en_US |
dc.identifier.citedreference | Vernon MO, Hayden MK, Trick WE, et al. Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: The effectiveness of source control to reduce the bioburden of vancomycin‐resistant Enterococci. Arch Intern Med 2006; 166: 306 – 312. | en_US |
dc.identifier.citedreference | Bleasdale SC, Trick WE, Gonzalez IM, et al. Effectiveness of chlorhexidine bathing to reduce catheter‐associated bloodstream infections in medical intensive care unit patients. Arch Intern Med 2007; 167: 2073 – 2079. | en_US |
dc.identifier.citedreference | Peterson LR, Singh K. Universal patient disinfection as a tool for infection control: Rub‐a‐dub‐dub, no need for a tub. Arch Intern Med 2006; 166: 274 – 276. | en_US |
dc.identifier.citedreference | CDC. Central Line‐Associated Bloodstream Infection (CLABSI): Event Guidelines and Procedures for Monitoring CLABSI. NHSN Manual 2010. http://www.cdc.gov/nhsn/psc_da.html. Accessed on February 28, 2012. | en_US |
dc.identifier.citedreference | CDC. Catheter‐Associated Bloodstream Infection Definitions: http://www.cdc.gov/nhsn/PDFs/pscManual/4PSC_CLABScurrentpdf 2008. Accessed on February 28, 2012. | en_US |
dc.identifier.citedreference | Srinivasan A, Bell WM, Cardo M, et al. Central Line‐Associated Blood Stream Infections—United States, 201, 2008, and 2009. MMWR 2011; 60: 243 – 248. | en_US |
dc.identifier.citedreference | Company WE. Statistical quality control handbook. 1956:OCLC 33858387. | en_US |
dc.identifier.citedreference | Kelly M, Conway M, Wirth K, et al. Moving CLABSI prevention beyond the intensive care unit: Risk factors in pediatric oncology patients. Infect Control Hosp Epidemiol 2011; 32: 1079 – 1085. | en_US |
dc.identifier.citedreference | Miller MR, Niedner MF, Huskins WC, et al. Reducing PICU central line‐associated bloodstream infections: 3‐Year results. Pediatrics 2011; 128: e1077 – 1083. | en_US |
dc.identifier.citedreference | Mollee P, Jones M, Stackelroth J, et al. Catheter‐associated bloodstream infection incidence and risk factors in adults with cancer: A prospective cohort study. J Hosp Infect 2011; 78: 26 – 30. | en_US |
dc.identifier.citedreference | Hatakeyama N, Hori T, Yamamoto M, et al. An evaluation of peripherally inserted central venous catheters for children with cancer requiring long‐term venous access. Int J Hematol 2011; 94: 372 – 377. | en_US |
dc.identifier.citedreference | Valentine KM. Ethanol lock therapy for catheter‐associated blood stream infections in a pediatric intensive care unit. Pediatr Crit Care Med 2011; 12: e292 – e296. | en_US |
dc.identifier.citedreference | Blackwood RA, Klein KC, Micel LN, et al. Ethanol locks therapy for resolution of fungal catheter infections. Pediatr Infect Dis J 2011; 30: 1105 – 1107. | en_US |
dc.identifier.citedreference | http://www.childrenshospitals.net/AM/Template.cfm?Section=Collaboratives1& Template=/CM/HTMLDisplay.cfm&ContentID=60780. Accessed on February 28, 2012. | en_US |
dc.identifier.citedreference | Mermel LA. Prevention of intravascular catheter‐related infections. Ann Intern Med 2000; 132: 391 – 402. | en_US |
dc.identifier.citedreference | Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994; 271: 1598 – 1601. | en_US |
dc.identifier.citedreference | Berenholtz SM, Pronovost PJ, Lipsett PA, et al. Eliminating catheter‐related bloodstream infections in the intensive care unit. Crit Care Med 2004; 32: 2014 – 2020. | en_US |
dc.identifier.citedreference | Sexton JB, Berenholtz SM, Goeschel CA, et al. Assessing and improving safety climate in a large cohort of intensive care units. Crit Care Med 2011; 39: 934 – 939. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.